Dr. Jordan A. Malenke, MD

Dr. Malenke practices at Maine Medical Partners Otolaryngology in Scarborough, Maine.

Dr. Malenke's NPI, 1275988313, was assigned on April 26, 2016. Dr. Malenke holds Maine license MD26065.

Dr. Malenke's primary practice is Maine Medical Partners Otolaryngology, at 92 Campus Dr, Scarborough, ME 04074 in Cumberland County. The practice phone is (207) 797-5753.

Dr. Malenke's primary practice is Maine Medical Partners Otolaryngology in Scarborough, Maine. Dr. Malenke is also affiliated with MaineHealth Maine Medical Center. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Malenke to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malenke practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Malenke's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Malenke's licenses on file in 2 states: Maine and Georgia.

CMS data shows 291 Medicare services from Dr. Malenke across 7 procedure codes in 2024, for 148 Medicare patients. Medicare paid $18,833 for them. Every service was in an office.

CMS counts 148 Medicare patients who saw Dr. Malenke in 2024. The largest group is 65 to 74, with 61 patients. 70% of them have high blood pressure, and 68% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Malenke's median patient age at 65, with 55% women.

In 2024, Dr. Malenke wrote 511 Medicare Part D claims for 147 patients. 98% of them were for generic drugs. CMS names the drug for 372 of them, across 10 drugs with 11 or more claims each, at $4,535 in total drug cost. In 2023, CMS named 239 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Malenke for performance year 2024, reported through an alternative payment model (APM). Dr. Malenke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malenke as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1 general payment to Dr. Malenke from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $113.